Wellington, NZ, 5th April 2017: Volpara Health Technologies (“Volpara”; ASX:VHT), a digital health company focused on early detection of breast cancer by improving quality of screening, is pleased to announce the commercial launch of VolparaEnterpriseTM 2.0 software, an enhanced version of VHT’s cloud- based breast imaging analytics platform, as foreshadowed by the prospectus in November 2016.
VolparaEnterpriseTM 2.0 software delivers real-time quality assurance and performance monitoring through dynamic, interactive dashboards that update over 100 key indicators and quality metrics with every mammography or tomosynthesis exam. With role-based access to such data, employees of large and small practices alike can perform rapid quality control checks that optimise the productivity and efficiency of imaging resources. In turn, this helps decrease costs through the reduction of retakes, increase employee effectiveness and enhance patient experience.
For further information please download PDF attached:
Download this document
